Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Clinical Case Reports|January 14, 2022
Hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS) following treatment with tisagenlecleucelReyes Maria Martín-Rojas, Ignacio Gómez-Centurión, Rebeca Bailén, et al.
Annals of Hematology|November 3, 2020
Post-transplant cyclophosphamide for GVHD prophylaxis compared to ATG-based prophylaxis in unrelated donor transplantationRebeca Bailén, Mi Kwon, María Jesús Pascual-Cascón, et al.
Transplantation and Cellular Therapy|January 6, 2024
Digital PCR Improves Sensitivity and Quantification in Monitoring CAR-T Cells in B Cell Lymphoma PatientsIsmael de la Iglesia-San Sebastián, Diego Carbonell, Mariana Bastos-Oreiro, et al.
International Journal of Hematology|September 23, 2021
Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibilityIgnacio Gómez-Centurión, Gillen Oarbeascoa, María Carmen García, et al.
Transplantation and Cellular Therapy|June 8, 2024
Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease after Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide: A Study on Behalf of the Spanish Hematopoietic Stem Cell Transplantation and Cellular Therapy Group (GETH)Ignacio Gómez-Centurión, Ana Isabel Gallardo Morillo, Ariadna Pérez Martínez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2023
Recent Bendamustine Treatment Before Apheresis Has a Negative Impact on Outcomes in Patients With Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell TherapyGloria Iacoboni, Víctor Navarro, Ana África Martín-López, et al.
Hemasphere|July 1, 2024
Efficacy and safety of bendamustine-containing bridging therapy in R/R LBCL patients receiving CD19 CAR T-cellsGloria Iacoboni, Mario A Sánchez-Salinas, Kai Rejeski, et al.
Bone Marrow Transplantation|July 24, 2025
ICANS risk model in CD19 CAR-T therapy: insights from serum and CSF cytokine profilingMarina Gomez-Llobell, Carlos Serra Smith, Daniel Gómez-Costas, et al.
Transplantation and Cellular Therapy|February 2, 2022
Post-Transplantation Cyclophosphamide After HLA Identical Compared to Haploidentical Donor Transplant in Acute Myeloid Leukemia: A Study on Behalf of GETH-TCRebeca Bailén, María Jesús Pascual-Cascón, Manuel Guerreiro, et al.
Transplantation and Cellular Therapy|March 7, 2026
Spanish real-world experience with belumosudil for chronic graft-versus-host disease after two or more prior lines of therapyRebeca Bailén, Felipe Peña-Muñoz, Arancha Bermúdez, et al.
Pageof 5